Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
Kiniksa Pharmaceuticals International, plc (KNSA) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $5.93B, a trailing price-to-earnings ratio of 78.4 and a free-cash-flow yield of 2.3%. Over the most recent reported fiscal year, revenue grew 60.1% and free cash flow per share grew 385.5%.